3-134603271-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_178554.6(KY):c.*308C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.619 in 225,278 control chromosomes in the GnomAD database, including 43,968 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.63 ( 30629 hom., cov: 31)
Exomes 𝑓: 0.59 ( 13339 hom. )
Consequence
KY
NM_178554.6 3_prime_UTR
NM_178554.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.23
Genes affected
KY (HGNC:26576): (kyphoscoliosis peptidase) The protein encoded by this gene belongs to the transglutaminase-like superfamily. The protein is involved in the function, maturation and stabilization of the neuromuscular junction and may be required for normal muscle growth. Mutations in this gene are associated with myopathy, myofibrillar, 7. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 3-134603271-G-A is Benign according to our data. Variant chr3-134603271-G-A is described in ClinVar as [Benign]. Clinvar id is 1267144.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.849 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KY | NM_178554.6 | c.*308C>T | 3_prime_UTR_variant | 11/11 | ENST00000423778.7 | NP_848649.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KY | ENST00000423778 | c.*308C>T | 3_prime_UTR_variant | 11/11 | 5 | NM_178554.6 | ENSP00000397598.2 |
Frequencies
GnomAD3 genomes AF: 0.630 AC: 95587AN: 151676Hom.: 30614 Cov.: 31
GnomAD3 genomes
AF:
AC:
95587
AN:
151676
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.595 AC: 43715AN: 73484Hom.: 13339 Cov.: 0 AF XY: 0.596 AC XY: 22028AN XY: 36970
GnomAD4 exome
AF:
AC:
43715
AN:
73484
Hom.:
Cov.:
0
AF XY:
AC XY:
22028
AN XY:
36970
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.630 AC: 95641AN: 151794Hom.: 30629 Cov.: 31 AF XY: 0.638 AC XY: 47298AN XY: 74162
GnomAD4 genome
AF:
AC:
95641
AN:
151794
Hom.:
Cov.:
31
AF XY:
AC XY:
47298
AN XY:
74162
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2503
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 06, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at